Article
Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population.
Cancer science - 1 Jun 2007
Jin Guangfu, Miao Ruifen, Deng Yimei, Hu Zhibin, Zhou Yan, Tan Yongfei, Wang Jianming, Hua Zhaolai, Ding Weiliang, Wang Lina, Chen Wensen, Shen Jing, Wang Xinru, Xu Yaochu, Shen Hongbing
Abstract excerpt
Epidermal growth factor (EGF), a ligand of the EGF receptor, plays a critical role in the development of gastric cancer. Genetic variants in its promoter region may influence transcription activity and contribute to gastric cancer predisposition. To test this hypothesis, we genotyped three EGF promoter polymorphisms (G61A, G-1380A, and A-1744G) in a case-control study of 675 gastric cancer cases and 704...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
